Literature DB >> 2280348

Nonlinear kinetics of the thiamine cation in humans: saturation of nonrenal clearance and tubular reabsorption.

W Weber1, M Nitz, M Looby.   

Abstract

The pharmacokinetics of thiamine in plasma and urine was investigated in 13 healthy and 3 renal-insufficient volunteers. Doses ranging from 5 to 200 mg thiamine hydrochloride were administered either as an iv bolus or a 50-min infusion. A sum of 3 exponentials was used as the unit impulse response function to characterize plasma kinetics. Drug input was mathematically described as a rectangular pulse of length 2 or 50 min. Total clearance, defined as the reciprocal of the area under the unit impulse response function, was found to depend on dose and creatinine clearance, as shown by a multiple nonlinear regression analysis. The nonrenal component of the total clearance was demonstrated to be dose-dependent, whereas its mean renal component was only dependent on creatinine clearance. At high plasma concentrations renal clearance approached renal plasma flow, and remained constant during the decline to near physiological plasma levels. With further decline under a characteristic threshold concentration, renal clearance decreased far below the glomerular filtration rate, indicating tubular reabsorption. Binding to plasma proteins was excluded by ultrafiltration experiments. The process of renal excretion can be described by a combination of glomerular filtration, flow-dependent tubular secretion, and saturable tubular reabsorption. The concentration dependency of renal clearance was reflected in its mean value, which was only 76% of its maximum value measured in the higher concentration range. In the dose range studied, most of the given dose had already been linearly excreted before tubular reabsorption became evident, and consequently the measured mean renal clearances did not differ enough from one another to exhibit the expected dose dependency. With increasing dose a shift of the cleared dose fraction from the nonrenal to the renal side was observed. Saturated nonrenal clearance alone could explain this effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280348     DOI: 10.1007/bf01073936

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  19 in total

1.  EXCRETION OF THIAMINE AND ITS METABOLITES IN THE URINE OF YOUNG ADULT MALES RECEIVING RESTRICTED INTAKES OF THE VITAMIN.

Authors:  Z Z Ziporin; W T Nunes; R C Powell; P P Waring; H E Sauberlich
Journal:  J Nutr       Date:  1965-03       Impact factor: 4.798

2.  Renal thiamine excretion in the dog; influence of parenteral administration of glucose.

Authors:  H N HAUGEN
Journal:  Scand J Clin Lab Invest       Date:  1961       Impact factor: 1.713

3.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

4.  Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters.

Authors:  L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

5.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

6.  A program for non-linear regression analysis to be used on desk-top computers.

Authors:  P Koeppe; C Hamann
Journal:  Comput Programs Biomed       Date:  1980-12

7.  Nervous tissue thiamine metabolism in vivo. I. Transport of thiamine and thiamine monophosphate from plasma to different brain regions of the rat.

Authors:  C Reggiani; C Patrini; G Rindi
Journal:  Brain Res       Date:  1984-02-20       Impact factor: 3.252

8.  Some properties of the thiamine uptake system in isolated rat hepatocytes.

Authors:  K Yoshioka
Journal:  Biochim Biophys Acta       Date:  1984-11-21

9.  Monophosphate, the only phosphoric ester of thiamin in the cerebro-spinal fluid.

Authors:  G Rindi; C Patrini; M Poloni
Journal:  Experientia       Date:  1981

10.  Determination of thiamine in human plasma and its pharmacokinetics.

Authors:  W Weber; H Kewitz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  11 in total

1.  Urinary excretion: does it accurately reflect relative differences in bioavailability/systemic exposure when renal clearance is nonlinear?

Authors:  Gary A Thompson; Roger D Toothaker
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

2.  Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors:  W Weber; M Looby; J Brockmöller
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

Review 3.  Nonlinear kinetics and the 1-exp function in nephropharmacology.

Authors:  F Keller; K Erdmann; M Giehl
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Effects of bladder resorption on pharmacokinetic data analysis.

Authors:  J T Dalton; M G Weintjes; J L Au
Journal:  J Pharmacokinet Biopharm       Date:  1994-06

5.  Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.

Authors:  Koji Kato; Haruyuki Mori; Tomoko Kito; Miyu Yokochi; Sumito Ito; Katsuhisa Inoue; Atsushi Yonezawa; Toshiya Katsura; Yuji Kumagai; Hiroaki Yuasa; Yoshinori Moriyama; Ken-ichi Inui; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2013-08-02       Impact factor: 4.200

6.  Involvement of organic cation transporters in the clearance and milk secretion of thiamine in mice.

Authors:  Koji Kato; Chihiro Moriyama; Naoki Ito; Xuan Zhang; Kenji Hachiuma; Naoko Hagima; Katsuya Iwata; Jun-ichi Yamaguchi; Kazuya Maeda; Kousei Ito; Hiroshi Suzuki; Yuichi Sugiyama; Hiroyuki Kusuhara
Journal:  Pharm Res       Date:  2015-02-21       Impact factor: 4.200

7.  Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally.

Authors:  C M Tallaksen; A Sande; T Bøhmer; H Bell; J Karlsen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 8.  Principles and clinical application of assessing alterations in renal elimination pathways.

Authors:  Susan E Tett; Carl M J Kirkpatrick; Annette S Gross; Andrew J McLachlan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  System analysis in multiple dose kinetics: evidence for saturable tubular reabsorption of the organic cation N1-methylnicotinamide in humans.

Authors:  W Weber; S Toussaint; M Looby; M Nitz; H Kewitz
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

10.  Accurate and precise plasma clearance measurement using four 99mTc-DTPA plasma samples over 4 h.

Authors:  Surajith N Wanasundara; Michal J Wesolowski; Mark C Barnfield; Michael L Waller; Anthony W Murray; Maria T Burniston; Paul S Babyn; Carl A Wesolowski
Journal:  Nucl Med Commun       Date:  2016-01       Impact factor: 1.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.